{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:40:26Z","timestamp":1787960426208,"version":"build-2784847793"},"reference-count":26,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"unspecified","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"LSI Medience Corporation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Soluble C-type lectin-like receptor 2 (sCLEC-2) is a new biomarker for platelet activation, which can be easily measured by usual blood collection. We conducted the CLECSTRO, a prospective, observational cohort study, to evaluate the clinical implications of sCLEC-2 in patients with acute ischaemic stroke (AIS) and transient ischaemic attack (TIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      The participants are patients with AIS\/TIA and control patients required for differentiation from AIS\/TIA. The target population is 600, including the patients and controls, who would be recruited from eight stroke centres across Japan. The inclusion criteria are AIS within 24 hours of onset and a modified Rankin Scale (mRS) score of 0\u20132, TIA within 7\u2009days of onset, and contemporary patients required for differentiation from AIS\/TIA. Plasma sCLEC-2 will be measured by high-sensitive chemiluminescent enzyme immunoassay using residual blood samples from routine laboratory examinations at the first visit in all patients and 7\u2009days later or at discharge in patients with AIS\/TIA. The outcomes include plasma levels of sCLEC-2 in patients with AIS\/TIA and controls, sCLEC-2\/D-dimer ratio in non-cardioembolic and cardioembolic AIS\/TIA, correlation of sCLEC-2 with recurrence or worsening of stroke, severity of stroke, infarct size, ABCD\n                      <jats:sup>2<\/jats:sup>\n                      score in TIA and outcome (mRS) at 7\u2009days and 3 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the Ethical Committee of the University of Yamanashi as the central ethical committee in agreement with the ethical committees of all collaborative stroke centres. Informed consent will be obtained by an opt-out form from the patients at each stroke centre according to the Ethical Guidelines for Medical and Biological Research Involving Human Subjects by the Japanese Ministry of Health, Labour and Welfare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05579405\">NCT05579405<\/jats:ext-link>\n                      , UMIN000048954\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-073708","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T23:06:20Z","timestamp":1695078380000},"page":"e073708","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Soluble C-type lectin-like receptor 2 in stroke (CLECSTRO) study: protocol of a multicentre, prospective cohort of a novel platelet activation marker in acute ischaemic stroke and transient ischaemic attack"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05579405","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-8190","authenticated-orcid":false,"given":"Shinichiro","family":"Uchiyama","sequence":"first","affiliation":[{"name":"Clinical Research Center for Medicine, International University of Health and Welfare, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-1451","authenticated-orcid":false,"given":"Katsue","family":"Suzuki-Inoue","sequence":"additional","affiliation":[{"name":"Department of Clinical and Laboratory Medicine, University of Yamanashi, Chuo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-8633","authenticated-orcid":false,"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of General and Laboratory Medicine, Mie Prefectural General Medical Centre, Yokkaichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3150-6157","authenticated-orcid":false,"given":"Yasushi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Centre, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2094-2428","authenticated-orcid":false,"given":"Teruyuki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Stroke and Cerebrovascular Medicine, Kyorin University, Mitaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-2467","authenticated-orcid":false,"given":"Takehiko","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-5502","authenticated-orcid":false,"given":"Hiroyuki","family":"Kinouchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Yamanashi, Chuo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-457X","authenticated-orcid":false,"given":"Ryo","family":"Itabashi","sequence":"additional","affiliation":[{"name":"Division of Neurology & Gerontology, Iwate Medical University, Shiwa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-3796","authenticated-orcid":false,"given":"Haruhiko","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-3337","authenticated-orcid":false,"given":"Koichi","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-7769","authenticated-orcid":false,"given":"Yutaka","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Showa General Hospital, Kodaira, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-8880","authenticated-orcid":false,"given":"Nobuo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mie Prefectural General Medical Centre, Yokkaichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-1653","authenticated-orcid":false,"given":"Hiroshi","family":"Sugimori","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Centre, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9495-2314","authenticated-orcid":false,"given":"Masahide","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Research and Development, LSI Medience Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"2025121601553302000_13.9.e073708.1","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2015.1021319"},{"key":"2025121601553302000_13.9.e073708.2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12185-019-02680-4","article-title":"Soluble CLEC-2 is generated independently of Adam10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI","volume":"110","author":"Inoue","year":"2019","journal-title":"Int J Hematol"},{"key":"2025121601553302000_13.9.e073708.3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688643","article-title":"The role of CLEC-2 and its ligands in thromboinflammation","volume":"12","author":"Meng","year":"2021","journal-title":"Front Immunol"},{"key":"2025121601553302000_13.9.e073708.4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132860","article-title":"Soluble C-type lectin-like receptor 2 is a biomarker for disseminated intravascular coagulation","volume":"10","author":"Yamamoto","year":"2021","journal-title":"J Clin Med"},{"key":"2025121601553302000_13.9.e073708.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.06.014","article-title":"Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated blunt traumatic brain injury","volume":"496","author":"Guo","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"2025121601553302000_13.9.e073708.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.21.4.637"},{"key":"2025121601553302000_13.9.e073708.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.192218"},{"key":"2025121601553302000_13.9.e073708.8","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.35"},{"key":"2025121601553302000_13.9.e073708.9","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000258355.23810.c6"},{"key":"2025121601553302000_13.9.e073708.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.20.7.864"},{"key":"2025121601553302000_13.9.e073708.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60150-0"},{"key":"2025121601553302000_13.9.e073708.12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12185-020-02983-x","article-title":"Expert consensus regarding standardization of sample preparation for clotting time assays","volume":"112","author":"Ieko","year":"2020","journal-title":"Int J Hematol"},{"key":"2025121601553302000_13.9.e073708.13","unstructured":"Adcock D , Hoefiner D , Kottke-Marchant K , et al . Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. fifth ed.Document H21A5. Wayne, PA: Clinical and Laboratory Standards Institute, 2008."},{"key":"2025121601553302000_13.9.e073708.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1994"},{"key":"2025121601553302000_13.9.e073708.15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702327200"},{"key":"2025121601553302000_13.9.e073708.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222273"},{"key":"2025121601553302000_13.9.e073708.17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/09537104.2021.2019694","article-title":"Early recognition of sepsis-induced coagulopathy using the C2PAC index: a ratio of soluble type C lectin-like receptor 2 (sCLEC-2) level and platelet count","volume":"33","author":"Ishikura","year":"2022","journal-title":"Platelets"},{"key":"2025121601553302000_13.9.e073708.18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.03.018","article-title":"Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy","volume":"178","author":"Yamashita","year":"2019","journal-title":"Thromb Res"},{"key":"2025121601553302000_13.9.e073708.19","first-page":"985","article-title":"Elevated plasma C-type lectin-like receptor 2 is associated with the worsening of coronavirus disease 2019","volume":"11","author":"Wada","year":"2022","journal-title":"J Clin Res"},{"key":"2025121601553302000_13.9.e073708.20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2023.01.018","article-title":"Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2Pac) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas","volume":"223","author":"Ando","year":"2023","journal-title":"Thromb Res"},{"key":"2025121601553302000_13.9.e073708.21","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ene.13984","article-title":"Plasma C-type lectin-like receptor 2 as a predictor of death and vascular events in patients with acute ischemic stroke","volume":"26","author":"Wu","year":"2019","journal-title":"Eur J Neurol"},{"key":"2025121601553302000_13.9.e073708.22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/STROKEAHA.118.022563","article-title":"Prognostic significance of plasma CLEC-2 (C-type lectin-like receptor 2) in patients with acute ischemic stroke","volume":"50","author":"Zhang","year":"2019","journal-title":"Stroke"},{"key":"2025121601553302000_13.9.e073708.23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10153408","article-title":"Soluble C-type lectin-like receptor 2 elevation in patients with acute cerebral infarction","volume":"10","author":"Nishigaki","year":"2021","journal-title":"J Clin Med"},{"key":"2025121601553302000_13.9.e073708.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.08.013"},{"key":"2025121601553302000_13.9.e073708.25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.505354"},{"key":"2025121601553302000_13.9.e073708.26","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996132"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-073708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:55:41Z","timestamp":1765878941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-073708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/bmjopen-2023-073708"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-073708","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}